Gomintia

Gomintia is a medicine authorised by Swissmedic under authorisation number 70541. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 December 2025 and the authorisation is valid without a time limit. ATC code L04AB06 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 70541
  • ATC L04AB06
  • Biotechnological medicines
Authorisation data
Authorisation number70541
NameGomintia
Full nameGomintia, Injektionslösung in einer Fertigspritze 50 mg/0.5 ml
Authorisation holderJanssen-Cilag AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AB06
First authorisation09 December 2025
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Gomintia, Injektionslösung in einer Fertigspritze 50 mg/0.5 mlB09 December 2025
2Gomintia, Injektionslösung in einer Fertigspritze 100 mg/1 mlB09 December 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Spritze(n)L04AB0607.15.0.B
21Spritze(n)L04AB0607.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Gomintia authorised in Switzerland?

Yes. Gomintia is authorised by Swissmedic under authorisation number 70541, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Gomintia have?

Gomintia is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Gomintia?

The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com